(S)-3-Benzyloxy-2-hydroxy-propionic acid methylester, 97.0%, 1g

9H-Fluoren-2-ol, 98%, 1g

5-(2-Chloroacetyl)-1-methyl-2,3-dihydro-1h-indol-2-one, 97%, 100mg

o-toluidina, mínimo 99,5 %, pa, 100 ml, envase de vidrio

1-Chloromethyl-4-methyl-benzene, 98.0%, 25g

2,3,5-Trifluorobenzonitrile, 98.0%, 250mg

(2S,3R,4S,5S)-5-((R)-1-hydroxy-2-(pivaloyloxy)ethyl)tetrahydrofuran-2,3,4-triyl tris(2,2-dimethylpropanoate), 98%, 250mg

{1-[(tert-butoxy)carbonyl]-1H-indazol-5-yl}boronic acid, 95%, 5g

3-Fluoro-2-(trifluoromethyl)benzamide, 250mg

3-Oxobutyl acetate, 95.0%, 1g

2-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-indazole, 95.0%, 5g

tert-Butyl 4-(pyrrolidin-3-yl)piperazine-1-carboxylate hydrochloride, 97%, 2.5g

TERT-BUTYL 4-(3-ACETYLPHENYL)PIPERIDINE-1-CARBOXYLATE, 95.0%, 500mg